Get Vaccinated Report Abuse/Neglect Sign up for E-news! Reproductive Health 988: 24/7 LIfeline
NMDOH Logo
Home Publications General
RSS Feed Icon

General


Photo of the publication cover. New Mexico Non-Resident/Fingerprint Card Scan Overview PowerPoint Caregivers Criminal History Screening - General April 28, 2023

New Mexico Non-Resident/Fingerprint Card Scan Overview PowerPoint



Photo of the publication cover. Fingerprint background check services Frequently Asked Questions (FAQs) Caregivers Criminal History Screening - General April 28, 2023

Fingerprint background check services Frequently Asked Questions (FAQs)



Photo of the publication cover. Map of Fingerprint Location Sites Caregivers Criminal History Screening - General April 28, 2023

Map of Fingerprint Location Sites



Photo of the publication cover. List of acceptable IDs needed for enrollment Caregivers Criminal History Screening - General April 28, 2023

List of acceptable IDs needed for enrollment



Photo of the publication cover. Guidance on Multi-factor Authentication Applications Caregivers Criminal History Screening - General April 28, 2023

Guidance on Multi-factor Authentication Applications



Photo of the publication cover. IDEMIA Background Check Result Access PowerPoint Caregivers Criminal History Screening - General April 28, 2023

IDEMIA Background Check Result Access PowerPoint



Photo of the publication cover. Metro and Northwest Region Health Promotion Team Northwest Public Health Region - General April 26, 2023

Northwest Region Health Promotion Team



Photo of the publication cover. CDC and FDA Update COVID-19 Vaccine Schedule Health Emergency Management - General April 21, 2023

The CDC and FDA have streamlined COVID-19 vaccine recommendations, authorizing the use of bivalent COVID-19 vaccines for all recommended doses. In addition, previously unvaccinated individuals ages 6 and older are now recommended to receive one dose of a bivalent COVID-19 vaccine, and people ages 65 and older and those with immune compromise can receive a second bivalent vaccine. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.





Photo of the publication cover. VFC Program Staff Listing Immunization - General April 13, 2023

VFC Program Staff Listing



Photo of the publication cover. Health Council Priorities FY23 rev 3-17-23 Northwest Public Health Region - General April 13, 2023

Health Council Priorities FY23 rev 3-17-23



Photo of the publication cover. Xylazine-related Overdose Warning Health Emergency Management - General April 7, 2023

The U.S. Drug Enforcement Agency (DEA) recently issued an alert regarding overdose deaths in the US linked to Xylazine, a non-opioid central nervous system depressant. It is used as a sedative, anesthetic, muscle relaxant, and analgesic in veterinary medicine and has not been approved for use in humans. Xylazine is usually mixed with other illicit drugs, like fentanyl, because it causes the effects of opioids to last longer. In New Mexico, six xylazine-involved deaths were reported in the last five years. Xylazine is an unscheduled drug that is easily accessed, so its presence in the illicit drug supply may increase over time, due to its low cost. Reports indicate that xylazine, alone or in combination with other drugs, is administered by injecting, snorting, swallowing, or inhaling it.



Photo of the publication cover. Stakeholder Engagement Link Developmental Disabilities - General April 6, 2023

Stakeholder engagement and participation is critical, and required, to ensure we capture the information needed to make the best decisions for the Department of Health, Developmental Disabilities Supports Division service delivery system for the Developmental Disabilities (DD) Waiver, Mi Via (MV) Waiver and the Medically Fragile (MF) Waiver.



Photo of the publication cover. NM ACQ Subcommittee Initial PowerPoint Developmental Disabilities - General April 6, 2023

NM ACQ Subcommittee Initial PowerPoint



Photo of the publication cover. NM ACQ Mathematical Rate Study PowerPoint Developmental Disabilities - General April 6, 2023

NM ACQ Mathematical Rate Study PowerPoint



Photo of the publication cover. 2023 Time Study FAQ Developmental Disabilities - General April 6, 2023

For any question not answered here, please contact Public Consulting Group via email or phone at NMHCBSRateStudy@pcgus.com or (833) 528-1736.



Photo of the publication cover. NM ACQ Email Communication 1.31.23 Developmental Disabilities - General April 6, 2023

Thank you again for participating in the ACQ Subcommittee Meeting that took place on January 10th. The Developmental Disabilities Supports Division (DDSD), who is working with Public Consulting Group LLC (PCG) heard valuable feedback which we used to improve the instructions and messaging of the rate study tools (the time study and cost report). Providers and vendors will receive instructions and invitations to training webinars this week.



Photo of the publication cover. Rate Study Mi Via Survey Developmental Disabilities - General April 6, 2023

The rate study is well underway for the Developmental Disabilities (DD), Mi Via (MV), and Medically Fragile (MF) Waiver services. Providers have received the cost report, and time study tools to prepare for completing them. These tools did not include Mi Via services, except for Consultant services. This is because in current policy, Mi Via rate ranges are based on what Medicaid currently pays for similar services under the Developmental Disabilities (DD) Waiver. Based on this policy, PCG’s recommended rate ranges for the Mi Via services in the scope of this rate study will be a range-based on the rate for the comparable DD Waiver services.



Photo of the publication cover. Rate Study Timelines Developmental Disabilities - General April 6, 2023

Rate Study Timelines



Photo of the publication cover. DDSD Numbered Memo 2023-02 Developmental Disabilities - General March 15, 2023

Instructions for smooth transition of services provided by terminated providers

« First | Prev | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next | Last »